Literature DB >> 32643464

Treating hidradenitis suppurativa during the COVID-19 pandemic: teledermatology exams of sensitive body areas.

Chidubem A V Okeke1, William D Shipman2, Jessica D Perry1, Michelle L Kerns3, Ginette A Okoye4, Angel S Byrd4.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32643464     DOI： 10.1080/09546634.2020.1781042

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN： 0954-6634            Impact factor:   3.359


× No keyword cloud information.
  2 in total

1.  Remote consultations for patients with hidradenitis suppurativa during the COVID-19 pandemic: a single-centre experience.

Authors:  N P Patel
Journal:  Clin Exp Dermatol       Date:  2021-05-21       Impact factor: 4.481

Review 2.  Teledermatology and Inflammatory Skin Conditions during COVID-19 Era: New Perspectives and Applications.

Authors:  Claudio Marasca; Maria Carmela Annunziata; Elisa Camela; Adriana Di Guida; Luigi Fornaro; Matteo Megna; Maddalena Napolitano; Cataldo Patruno; Luca Potestio; Gabriella Fabbrocini
Journal:  J Clin Med       Date:  2022-03-10       Impact factor: 4.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.